Compare
NAVs as of 20 Aug 2026
Mirae Asset CRISIL-IBX Financial Services 9-12 Months Debt Index FundRegularICICI Prudential NASDAQ 100 Index FundRegularMotilal Oswal S&P 500 Index FundRegularUTI Nifty 500 Value 50 Index FundRegular4 of 4 funds
Comparing the maximum of 4. Replace which fund?
Growth of ₹100 (rebased over the selected window)
Common period 26 Jun 2025 – 20 Aug 2026, limited by Mirae Asset CRISIL-IBX Financial Services 9-12 Months Debt Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Mirae Asset CRISIL-IBX Financial Services 9-12 Months Debt Index Fund | ICICI Prudential NASDAQ 100 Index Fund | Motilal Oswal S&P 500 Index Fund | UTI Nifty 500 Value 50 Index Fund | Nasdaq 100 | S&P 500 | Nifty 500 |
|---|---|---|---|---|---|---|---|
| 26 Jun 2025 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 | ₹100.00 |
| 31 Jul 2025 | ₹100.67 | ₹105.42 | ₹105.44 | ₹97.35 | ₹103.43 | ₹103.23 | ₹97.44 |
| 04 Sep 2025 | ₹101.19 | ₹107.99 | ₹108.75 | ₹98.10 | ₹105.28 | ₹105.88 | ₹97.03 |
| 09 Oct 2025 | ₹101.78 | ₹115.43 | ₹113.48 | ₹103.01 | ₹111.81 | ₹109.67 | ₹98.83 |
| 13 Nov 2025 | ₹102.36 | ₹114.77 | ₹113.35 | ₹107.55 | ₹111.34 | ₹109.71 | ₹101.27 |
| 18 Dec 2025 | ₹102.80 | ₹116.70 | ₹115.99 | ₹105.23 | ₹111.46 | ₹110.32 | ₹99.89 |
| 22 Jan 2026 | ₹103.11 | ₹120.85 | ₹120.06 | ₹109.97 | ₹113.68 | ₹112.58 | ₹97.84 |
| 26 Feb 2026 | ₹103.79 | ₹117.65 | ₹119.05 | ₹119.73 | ₹111.53 | ₹112.50 | ₹99.71 |
| 02 Apr 2026 | ₹104.19 | ₹115.84 | ₹116.27 | ₹107.11 | ₹107.12 | ₹107.19 | ₹89.03 |
| 07 May 2026 | ₹104.95 | ₹139.76 | ₹130.98 | ₹118.63 | ₹127.25 | ₹119.48 | ₹98.71 |
| 11 Jun 2026 | ₹105.40 | ₹145.48 | ₹134.13 | ₹113.14 | ₹131.18 | ₹120.41 | ₹94.03 |
| 16 Jul 2026 | ₹106.31 | ₹144.15 | ₹137.48 | ₹112.39 | ₹129.31 | ₹122.68 | ₹98.79 |
| 20 Aug 2026 | ₹107.07 | ₹143.97 | ₹138.48 | ₹112.71 | ₹130.23 | ₹125.09 | ₹99.98 |
| Metric | Mirae Asset · Regular NAV ₹10.71 Moderate risk ★★★★★ 1Y | ICICI Prudential · Regular NAV ₹23.75 Very High risk ★★★★☆ | Motilal Oswal · Regular NAV ₹32.55 Very High risk ★★★★☆ | UTI · Regular NAV ₹21.85 Very High risk ★★★★☆ | Category median Index Funds · 366 funds |
|---|---|---|---|---|---|
| +6.03% | +37.18%Best in row | +31.00% | +13.89% | +5.43% | |
| — | +31.12%Best in row | +25.86% | +24.71% | +8.41% | |
| — | — | +17.23% | — | +8.95% | |
| +6.12% | +19.42% | +20.87% | +27.33%Best in row | +7.40% | |
| +6.38% | +28.64%Best in row | +23.17% | +15.10% | — | |
| — | +25.79% | +17.23% | +27.92%Best in row | +11.37% | |
| — | — | +17.27% | — | +13.00% | |
| Risk | |||||
| 0.54%Best in row | 21.33% | 15.42% | 20.79% | 13.88% | |
| -0.87 | 1.15 | 1.26Best in row | 0.88 | 0.25 | |
| -1.25 | 1.71 | 1.85Best in row | 1.17 | 0.35 | |
| -0.21%Best in row | -30.20% | -20.14% | -22.84% | -16.66% | |
| — | Nasdaq 100 | S&P 500 | Nifty 500 | — | |
| — | +4.64% | +4.30% | +11.05%Best in row | +0.30% | |
| — | 0.99 | 1.02 | 1.14 | 1.00 | |
| — | 108.9% | 112.7% | 138.5%Best in row | 101.3% | |
| — | 90.5% | 91.3% | 91.5% | 98.8% | |
| 0.29%Best in row | 1.06% | 1.06% | 1.24% | 0.96% | |
| ₹111.68Cr | ₹3,348Cr | ₹4,500Cr | ₹729.68Cr | ₹182.17Cr | |
| None | — | 1.00% | None | — | |
| ₹99 | ₹100 | ₹500 | ₹500 | — | |
| ₹5.00K | ₹1.00K | ₹500 | ₹1.00K | — | |
| — | 16% | 1% | 44% | 35% | |
| Pranavi Kulkarni · 0.5y | Sharmila D'silva | Rakesh Shetty | Sharwan Kumar Goyal | — | |
| 26 Jun 2025 | 19 Oct 2021 | 29 Apr 2020 | 12 May 2023 | — | |
| — | — | — | 50 | — | |
| — | — | — | 48.8% | — | |
| 5.6% | 0.1% | 0.5% | 0.1% | — | |
3 rows carry the same value for every fund — show
- 10Y return (CAGR)
- —
- 10Y rolling avg
- —
- Lock-in
- None
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.